A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

Status:
Completed

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

The purpose of this study is to compare the safety and effect of TTP054 versus placebo on glucose control in patients with type 2 diabetes.

Phase 2

vTv Therapeutics